Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
445 |
|
Actual shortage: | 46 (10%) | |
Anticipated shortage: | 15 (3%) | |
Avoided shortage: | 8 (2%) | |
Resolved: | 376 (84%) | |
Discontinuation Reports |
68 |
|
To be discontinued: | 7 (10%) | |
Discontinued: | 51 (75%) | |
Reversed: | 10 (15%) | |
Late reports |
44 (9%) |
|
Overdue reports |
12 (18%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CLARITHROMYCIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-01-07 | 2019-02-06 | 71374 |
PANTOPRAZOLE T | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-07 | 2019-05-28 | 71379 |
BACLOFEN | 10MG | TABLET | Resolved | 2019-01-10 | 2019-01-25 | 71821 |
QUETIAPINE | 100MG | TABLET | Resolved | 2019-01-15 | 2019-02-20 | 72239 |
ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72242 |
CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-01-15 | 2019-02-28 | 72248 |
VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2019-01-15 | 2019-02-13 | 72253 |
CANDESARTAN | 4MG | TABLET | Resolved | 2019-01-25 | 2019-05-16 | 73514 |
CANDESARTAN | 16MG | TABLET | Resolved | 2019-01-25 | 2019-02-26 | 73517 |
CANDESARTAN | 32MG | TABLET | Resolved | 2019-01-25 | 2019-04-24 | 73520 |
PAROXETINE | 10MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73656 |
PAROXETINE | 20MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73659 |
PAROXETINE | 30MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73662 |
ENALAPRIL | 2MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73668 |
ENALAPRIL | 4MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73671 |
ENALAPRIL | 8MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73674 |
ENALAPRIL | 16MG | TABLET | Resolved | 2019-01-28 | 2022-08-30 | 73677 |
ALMOTRIPTAN | 12.5MG | TABLET | Resolved | 2019-01-28 | 2019-03-28 | 73682 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2019-02-11 | 2019-03-02 | 75262 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TERAZOSIN | 5MG | TABLET | To be discontinued | 2021-12-16 | 2021-12-16 | 151284 |
LORAZEPAM | 2.0MG | TABLET | Discontinued | 2021-12-16 | 2021-12-17 | 151293 |
BUPROPION SR | 100MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151302 |
BUPROPION SR | 150MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2021-12-16 | 2021-12-17 | 151307 |
SOLIFENACIN | 5MG | TABLET | Discontinued | 2023-09-26 | 2023-09-26 | 205215 |
DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
RISEDRONATE | 35MG | TABLET | Discontinued | 2024-02-28 | 2024-02-29 | 220861 |